SG149854A1 - Amine salt of carbostyril derivative - Google Patents
Amine salt of carbostyril derivativeInfo
- Publication number
- SG149854A1 SG149854A1 SG200900369-0A SG2009003690A SG149854A1 SG 149854 A1 SG149854 A1 SG 149854A1 SG 2009003690 A SG2009003690 A SG 2009003690A SG 149854 A1 SG149854 A1 SG 149854A1
- Authority
- SG
- Singapore
- Prior art keywords
- amine salt
- carbostyril derivative
- carbostyril
- derivative
- amine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004013402 | 2004-01-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG149854A1 true SG149854A1 (en) | 2009-02-27 |
Family
ID=34805383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200900369-0A SG149854A1 (en) | 2004-01-21 | 2005-01-20 | Amine salt of carbostyril derivative |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7732611B2 (zh) |
| EP (2) | EP1706383B1 (zh) |
| JP (1) | JP4516962B2 (zh) |
| KR (1) | KR100844762B1 (zh) |
| CN (1) | CN1934086B (zh) |
| AR (1) | AR047438A1 (zh) |
| AT (1) | ATE549318T1 (zh) |
| AU (1) | AU2005206430B2 (zh) |
| BR (1) | BRPI0506982A (zh) |
| CA (1) | CA2553231C (zh) |
| CY (2) | CY1112723T1 (zh) |
| DK (2) | DK2253619T3 (zh) |
| ES (2) | ES2544327T3 (zh) |
| HK (2) | HK1101327A1 (zh) |
| HU (1) | HUE027990T2 (zh) |
| MY (1) | MY148416A (zh) |
| PL (2) | PL2253619T3 (zh) |
| PT (2) | PT1706383E (zh) |
| RU (1) | RU2372336C2 (zh) |
| SG (1) | SG149854A1 (zh) |
| SI (2) | SI1706383T1 (zh) |
| TW (1) | TWI340650B (zh) |
| WO (1) | WO2005070892A1 (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6187197B1 (en) * | 1998-10-28 | 2001-02-13 | Marvin Haddock | Multi-stage engine coolant recycling process |
| TWI340650B (en) * | 2004-01-21 | 2011-04-21 | Otsuka Pharma Co Ltd | Amine saly of carbostyril derivative |
| WO2009022674A1 (en) * | 2007-08-10 | 2009-02-19 | Otsuka Pharmaceutical Co., Ltd. | Medical composition containing rebamipide |
| WO2009126695A2 (en) * | 2008-04-08 | 2009-10-15 | Dynamis Therapeutics, Inc. | Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes |
| KR20110027786A (ko) * | 2008-06-19 | 2011-03-16 | 오츠카 세이야쿠 가부시키가이샤 | 레바미피드를 함유하는 의약 조성물 |
| CN103476753B (zh) * | 2011-02-25 | 2015-12-09 | 诺弗米克斯有限公司 | 新的瑞巴派特复合物和共晶体 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS517614Y2 (zh) * | 1971-02-12 | 1976-03-01 | ||
| US4578381A (en) * | 1982-07-05 | 1986-03-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| JPS597168A (ja) | 1982-07-05 | 1984-01-14 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
| DE69207560T2 (de) * | 1991-06-07 | 1996-06-27 | Otsuka Pharma Co Ltd | Antidiabetikum |
| TW227558B (zh) * | 1992-05-14 | 1994-08-01 | Otsuka Pharma Co Ltd | |
| US5415872A (en) | 1992-06-22 | 1995-05-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
| JP2872546B2 (ja) * | 1992-11-26 | 1999-03-17 | 大塚製薬株式会社 | 腸粘膜障害保護剤 |
| US5637597A (en) * | 1993-10-21 | 1997-06-10 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives for inhibiting production of interleukin-8 |
| WO1995012579A1 (en) | 1993-11-05 | 1995-05-11 | Otsuka Pharmaceutical Company, Limited | Bismuth salt of carbostyril derivatives for the treatment of peptic ulcers |
| JP3621463B2 (ja) | 1995-04-26 | 2005-02-16 | 大塚製薬株式会社 | カルボスチリル誘導体ビスマス塩 |
| AR004214A1 (es) * | 1995-10-12 | 1998-11-04 | Otsuka Pharma Co Ltd | Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas |
| GB9613455D0 (en) * | 1996-06-27 | 1996-08-28 | Aston Molecules Ltd | Analogues or derivatives of quercetin |
| TW200304813A (en) | 2002-03-11 | 2003-10-16 | Novartis Ag | Salts of organic acid |
| KR20040104020A (ko) | 2003-06-02 | 2004-12-10 | 진양제약주식회사 | 신규 레바미피드 리지네이트와 레바미피드 아르기니네이트및 이 신규 레바미피드 리지네이트와 레바미피드아르기니네이트를 유효성분으로 함유하는 약학적 제제 |
| TWI340650B (en) * | 2004-01-21 | 2011-04-21 | Otsuka Pharma Co Ltd | Amine saly of carbostyril derivative |
| JP4719917B2 (ja) | 2007-03-30 | 2011-07-06 | 国立大学法人 岡山大学 | アズキ加工食品のアズキ原料品種判定方法 |
-
2005
- 2005-01-18 TW TW094101386A patent/TWI340650B/zh not_active IP Right Cessation
- 2005-01-19 MY MYPI20050200A patent/MY148416A/en unknown
- 2005-01-20 US US10/586,453 patent/US7732611B2/en not_active Expired - Fee Related
- 2005-01-20 RU RU2006129945/04A patent/RU2372336C2/ru not_active IP Right Cessation
- 2005-01-20 PL PL10174397T patent/PL2253619T3/pl unknown
- 2005-01-20 HU HUE05704144A patent/HUE027990T2/en unknown
- 2005-01-20 DK DK10174397.9T patent/DK2253619T3/da active
- 2005-01-20 CA CA2553231A patent/CA2553231C/en not_active Expired - Fee Related
- 2005-01-20 ES ES05704144.4T patent/ES2544327T3/es active Active
- 2005-01-20 ES ES10174397T patent/ES2382133T3/es active Active
- 2005-01-20 AT AT10174397T patent/ATE549318T1/de active
- 2005-01-20 SI SI200531992T patent/SI1706383T1/sl unknown
- 2005-01-20 WO PCT/JP2005/001034 patent/WO2005070892A1/en active Application Filing
- 2005-01-20 SI SI200531494T patent/SI2253619T1/sl unknown
- 2005-01-20 KR KR1020067016600A patent/KR100844762B1/ko active IP Right Grant
- 2005-01-20 CN CN2005800086478A patent/CN1934086B/zh not_active Expired - Fee Related
- 2005-01-20 PT PT57041444T patent/PT1706383E/pt unknown
- 2005-01-20 AU AU2005206430A patent/AU2005206430B2/en not_active Ceased
- 2005-01-20 EP EP05704144.4A patent/EP1706383B1/en not_active Not-in-force
- 2005-01-20 AR ARP050100199A patent/AR047438A1/es not_active Application Discontinuation
- 2005-01-20 PT PT10174397T patent/PT2253619E/pt unknown
- 2005-01-20 JP JP2006520510A patent/JP4516962B2/ja active Active
- 2005-01-20 PL PL05704144T patent/PL1706383T3/pl unknown
- 2005-01-20 SG SG200900369-0A patent/SG149854A1/en unknown
- 2005-01-20 EP EP10174397A patent/EP2253619B1/en not_active Not-in-force
- 2005-01-20 BR BRPI0506982-3A patent/BRPI0506982A/pt not_active IP Right Cessation
- 2005-01-20 DK DK05704144.4T patent/DK1706383T3/en active
-
2007
- 2007-08-24 HK HK07109247.5A patent/HK1101327A1/xx not_active IP Right Cessation
-
2010
- 2010-04-26 US US12/662,610 patent/US8222276B2/en not_active Expired - Fee Related
-
2011
- 2011-03-17 HK HK11102692.4A patent/HK1148527A1/xx not_active IP Right Cessation
-
2012
- 2012-05-11 CY CY20121100442T patent/CY1112723T1/el unknown
-
2015
- 2015-10-06 CY CY20151100891T patent/CY1116773T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG141459A1 (en) | Novel quinoline derivatives | |
| ZA200610593B (en) | Diphenylimidazopyrimidine and -imidazole amines as inhibitors of ß-secretase | |
| SG147409A1 (en) | Amide derivatives | |
| PL1761520T3 (pl) | Inhibitory kinazy | |
| TW200640924A (en) | VEGF-R2 inhibitors and methods | |
| HK1131055A1 (en) | Novel benzylamine derivatives as cetp inhibitors | |
| IN2014CN03629A (zh) | ||
| SG143985A1 (en) | Quinolinone derivatives | |
| SG149891A1 (en) | Indazole derivatives as inhibitors of hormone-sensitive lipases | |
| HK1099297A1 (en) | Quinoline derivatives for use as mycobacterial inhibitors | |
| IL184303A0 (en) | Amino-pyridines as inhibitors of ??-secretase | |
| HK1124233A1 (en) | Quinoline derivatives as antibacterical agents | |
| PT1828167E (pt) | Derivados de acrilamida como agentes antibióticos | |
| SG149831A1 (en) | Benzimidazole derivatives | |
| DE602004017623D1 (de) | N-substituierte pyrazolyl-amidyl-benzimidazolyl-c-kit-inhibitoren | |
| MY143516A (en) | Kinase inhibitors | |
| IL181897A0 (en) | Cyclic amine derivative or salt thereof | |
| SG149854A1 (en) | Amine salt of carbostyril derivative | |
| TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
| SG142306A1 (en) | Methods for neuroprotection | |
| GB0422439D0 (en) | Inhibitors of infection | |
| SG144920A1 (en) | Method and intermediates for the preparation of derivatives of n-(1- benzhydrylazetidin-3-yl)-n-phenylmethylsulphonamide | |
| TWM292236U (en) | Hanging apparatus of earphone | |
| UA97130C2 (en) | Cyclopamine derivatives | |
| HRP20060137A2 (zh) |